Form 4: Myla Lai Goldman Acquires 1,071 Shares of West Pharmaceutical Services Inc. (WST) Restricted Stock
SEC Form 4 Filing
Director Myla Lai Goldman acquired 1,071 shares of West Pharmaceutical Services Inc. restricted stock on May 6, 2025, which will vest at the next annual shareholder meeting.
Summary
- On May 6, 2025, Myla Lai Goldman, a director of West Pharmaceutical Services Inc. (WST), acquired 1,071 shares of common stock.
- These shares were acquired as restricted stock units at a price of $0.
- Following the transaction, Goldman directly owns 19,423.93 shares of WST common stock.
- The restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
- A Limited Power of Attorney was executed on May 15, 2024, authorizing Luis Cantarero, Louis Lalli, Ryan Metz, and Caitlin Hippeli to act on behalf of Myla Lai-Goldman for Section 16(a) filings.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard insider activity related to compensation and alignment with company performance. The acquisition of shares by a director is generally viewed favorably.
Positives
- The acquisition of restricted stock units indicates continued alignment of the director's interests with the company's long-term performance.
Future Outlook
The restricted stock units will vest at the next annual shareholder meeting, aligning the director's interests with the company's performance.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The acquisition of shares by a director can positively influence shareholder confidence.
Next Steps
- The restricted stock units will vest at the next annual shareholder meeting.
Key Dates
| Date | Description |
|---|---|
| 2024-05-15 | Date of execution for the Limited Power of Attorney. |
| 2025-05-06 | Date of transaction: Myla Lai Goldman acquired 1,071 shares of restricted stock. |
| Next annual shareholder meeting | Vesting date for the acquired restricted stock units. |
| 2025-05-08 | Date of signature for the Form 4 filing. |
Keywords
West Pharmaceutical Services, Myla Lai Goldman, restricted stock units, Form 4, beneficial ownership, director, WST, acquisition, Section 16(a), power of attorney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.